Clinical Trials Directory

Trials / Conditions / Vestibular Schwannoma

Vestibular Schwannoma

59 registered clinical trials studyying Vestibular Schwannoma15 currently recruiting.

StatusTrialSponsorPhase
WithdrawnRole of ChatGPT in Vestibular Schwannoma Management
NCT06163664
University of Southern CaliforniaN/A
Enrolling By InvitationLong Term Follow-up Study of AAVAnc80-antiVEGF Gene Therapy
NCT07503613
Akouos, Inc.
Not Yet RecruitingMeasuring Vestibular Organ Function With Weak Alternating Current Stimulation
NCT07267910
Aalto UniversityN/A
Not Yet RecruitingSteroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients
NCT07116811
Beijing Tiantan HospitalPhase 3
RecruitingVestibular Rehabilitation Protocol in Unilateral Vestibular Schwannoma
NCT07364955
Albert Torrents TorreroN/A
Active Not RecruitingMapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular Schwannoma
NCT07130851
Marketa BonaventurovaN/A
RecruitingEarly Rehabilitation Using Head Impulse Test for Acute Vestibular Deficit
NCT06660082
Hospices Civils de LyonN/A
RecruitingAnti-VEGF Gene Therapy Trial for Vestibular Schwannoma
NCT06517888
Akouos, Inc.Phase 1 / Phase 2
RecruitingUSPIO Enhanced MR Imaging in CNS Tumours (UMIC)
NCT06572475
Northern Care Alliance NHS Foundation TrustN/A
RecruitingEvolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgery
NCT06112509
Centre Hospitalier Universitaire de BesanconN/A
RecruitingEvaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas
NCT05702749
Medical College of WisconsinN/A
RecruitingRadiosurgery Induced Ototoxicity in Patients Treated for a Vestibular Schwannoma
NCT05641441
University Hospital, Geneva
UnknownRemote Ischemic Preconditioning in Vestibular Schwannoma Surgery
NCT05567341
University Hospital TuebingenN/A
RecruitingStableEyes With Active Neurofeedback
NCT05622344
Johns Hopkins UniversityN/A
TerminatedEnhancing Facial Nerve Function With Omega-3 After Resection of Vestibular Schwannoma
NCT05116878
Mayo ClinicN/A
CompletedMicroscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560
NCT04351373
Mayo ClinicPhase 2
RecruitingEvolution of Balance and Vestibular Function in Patients Treated With Gammaknife Radiosurgery for Vestibular S
NCT04859335
University Hospital, ToulouseN/A
UnknownNimodipine in Vestibular Schwanommas
NCT04801953
Medical University of ViennaPhase 2
UnknownMR Fingerprinting for Vestibular Schwannomas
NCT04851925
Medical University of Vienna
UnknownVestibular Precision: Physiology & Pathophysiology
NCT04890132
Massachusetts Eye and Ear InfirmaryN/A
Active Not RecruitingInnovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF
NCT04374305
Scott R. Plotkin, MD, PhDPhase 2
CompletedVestibular Schwannoma Organoids
NCT05786144
Maastricht Radiation Oncology
CompletedTriamcinolone Levels in Cochlear Perilymph, Lateral Canal and CSF
NCT04658836
Medical University of ViennaPhase 1
CompletedAuditory Nerve Test System During Vestibular Schwannoma Resection
NCT04241679
Washington University School of MedicineN/A
TerminatedLongitudinal Recovery of Laboratory, Clinical, and Community-Based Measures of Head and Trunk Control in Peopl
NCT04594057
University of UtahN/A
WithdrawnAnalysis of Vestibular Compensation Following Clinical Intervention for Vestibular Schwannoma
NCT04196933
Massachusetts Eye and Ear InfirmaryN/A
CompletedUse of DTT to Define Facial Nerve Position in Vestibular Schwannomas
NCT04057976
King's College Hospital NHS TrustN/A
UnknownNovel Multimodality Imaging for Navigation in Skull Base Surgery
NCT04128345
University College, London
RecruitingCI Following VS Removal or Labyrinthectomy
NCT03795675
Ohio State UniversityN/A
CompletedSimultaneous Cochlear Implantation During Translabyrinthine Resection of Vestibular Schwannoma
NCT03958006
Henry Ford Health SystemN/A
CompletedVegetative Monitoring During Brainstem-associated Surgery
NCT03666507
University Hospital Tuebingen
RecruitingCochlear Implantation After Gamma Knife Radiosurgery with EABR and Correlation to Postoperative Hearing Result
NCT03745534
Christoph Arnoldner
Active Not RecruitingStudy of Aspirin in Patients With Vestibular Schwannoma
NCT03079999
Massachusetts Eye and Ear InfirmaryPhase 2
UnknownSecondary Endolymphatic Hydrops and Vestibular Schwannomas on 3 Tesla MRI
NCT03593577
University Hospital, Strasbourg, France
CompletedConsequence of Unilateral Vestibular Loss on Visual Abilities
NCT03581331
Assistance Publique Hopitaux De MarseilleN/A
UnknownProtocol for Evaluating a Planning Algorithm for Gamma Knife Radiosurgery
NCT03520829
Assistance Publique Hopitaux De Marseille
CompletedWES of NF2-associated in Comparison to Sporadic Vestibular Schwannomas - Correlation With Clinical Data
NCT03210285
University Hospital Tuebingen
RecruitingIntraoperative EABR for Decision Making
NCT03745560
Christoph Arnoldner
TerminatedTrial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors
NCT03095248
Children's Hospital Medical Center, CincinnatiPhase 2
Active Not RecruitingVestibular Outcomes in Vestibular Schwannoma
NCT03346889
Haukeland University Hospital
UnknownResponse Prediction After GKS in Patients With Vestibular Schwannoma Using DCE MR Imaging
NCT03097822
Seoul National University Hospital
CompletedIcotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
NCT02934256
Li PengPhase 2
CompletedRole of Psychiatric Profile in Prehabituated Patients After Vestibular Schwannoma Surgery
NCT03638310
Charles University, Czech RepublicN/A
TerminatedExploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Me
NCT02282917
Massachusetts Eye and Ear InfirmaryEARLY_Phase 1
WithdrawnGentamicin Treatment Prior to Schwannoma Surgery - No Residual Function
NCT02415257
Lund UniversityPhase 4
WithdrawnGentamicin Treatment Prior to Schwannoma Surgery - Residual Function
NCT02379754
Lund UniversityPhase 4
UnknownPreoperative Vestibular Rehabilitation Effectiveness After Vestibular Schwannoma Surgery
NCT02275325
Central Hospital, Nancy, FranceN/A
CompletedVestibular Schwannoma - Radiosurgery or Expectation: V-REX.
NCT02249572
Haukeland University HospitalN/A
CompletedVertigo Perception and Quality of Life in Patients After Surgical Treatment of Vestibular Schwannoma
NCT02963896
University Hospital, MotolN/A
CompletedEndostatin Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
NCT02104323
Beijing Tiantan HospitalPhase 2
CompletedGamma Knife Radiosurgery vs Initial Conservative Treatment for Vestibular Schwannoma Patients With Preserved H
NCT01938677
Karolinska InstitutetN/A
UnknownVestibular Schwannoma and Psychological Factors
NCT01743248
Central Hospital, Nancy, France
UnknownStereotactic Radiation in Vestibular Schwannoma
NCT01449604
Ramathibodi HospitalPhase 3
SuspendedSuper-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Vestibular Schwannom
NCT01083966
Northwell HealthPhase 1
Active Not RecruitingHearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma
NCT01199978
Massachusetts General HospitalPhase 2
CompletedBevacizumab for Symptomatic Vestibular Schwannoma in Neurofibromatosis Type 2 (NF2)
NCT01207687
National Cancer Institute (NCI)Phase 2
CompletedLapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
NCT00973739
NYU Langone HealthPhase 2
CompletedConcentration and Activity of Lapatinib in Vestibular Schwannomas
NCT00863122
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsEARLY_Phase 1
CompletedRecovery of Visual Acuity in People With Vestibular Deficits
NCT00411216
Emory UniversityN/A